1 LATANOPROST | 30 of 1210 | 2440 prescriptions Less than 1% of all prescriptions | | 740 patients 32% of all patients | < 11 | |
2 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 20 of 90 | 1110 prescriptions Less than 1% of all prescriptions | | 390 patients 17% of all patients | < 11 | |
3 TIMOLOL MALEATE | 30 of 480 | 720 prescriptions Less than 1% of all prescriptions | 720 | 300 patients 13% of all patients | 300 patients 13% of all patients | |
4 LUMIGAN (BIMATOPROST) | 40 of 300 | 650 prescriptions Less than 1% of all prescriptions | 650 | 200 patients 9% of all patients | 200 patients 9% of all patients | |
5 COMBIGAN (BRIMONIDINE TARTRATE/TIMOLOL) | 10 of 330 | 630 prescriptions Less than 1% of all prescriptions | 630 | 180 patients 8% of all patients | 180 patients 8% of all patients | |
6 DORZOLAMIDE HCL | 20 of 110 | 370 prescriptions Less than 1% of all prescriptions | 370 | 140 patients 6% of all patients | 140 patients 6% of all patients | |
7 TRAVATAN Z (TRAVOPROST) | 30 of 370 | 450 prescriptions Less than 1% of all prescriptions | 450 | 140 patients 6% of all patients | 140 patients 6% of all patients | |
8 BRIMONIDINE TARTRATE | 50 of 180 | 280 prescriptions Less than 1% of all prescriptions | | 120 patients 5% of all patients | < 11 | |
9 RESTASIS (CYCLOSPORINE) | 40 of 380 | 370 prescriptions Less than 1% of all prescriptions | | 150 patients 6% of all patients | < 11 | |
10 SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TART) | 20 of 60 | 270 prescriptions Less than 1% of all prescriptions | 270 | < 11 | < 11 | |
11 PREDNISOLONE ACETATE | 200 of 360 | 150 prescriptions Less than 1% of all prescriptions | 150 | 130 patients 6% of all patients | 130 patients 6% of all patients | |
12 NEOMYCIN-POLYMYXIN-DEXAMETH (NEOMYCIN/POLYMYXIN B/DEXAMETHA) | 170 of 360 | 150 prescriptions Less than 1% of all prescriptions | 150 | 120 patients 5% of all patients | 120 patients 5% of all patients | |
13 PAZEO (OLOPATADINE HCL) | 40 of 50 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |